These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23460713)

  • 1. Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?
    Hansen AR; Siu LL
    J Clin Oncol; 2013 Apr; 31(11):1381-3. PubMed ID: 23460713
    [No Abstract]   [Full Text] [Related]  

  • 2. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
    Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
    Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of taxanes and targeted therapies in locally advanced head and neck cancer.
    Specenier P; Vermorken JB
    Curr Opin Oncol; 2007 May; 19(3):195-201. PubMed ID: 17414636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck.
    Burtness B
    J Clin Oncol; 2005 Aug; 23(24):5440-2. PubMed ID: 16009959
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does TPF improve survival over PF?
    Devisetty K; Wong SJ; Mell LK
    Lancet Oncol; 2011 May; 12(5):419-20; author reply 421-2. PubMed ID: 21536218
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study.
    Noronha V; Goswami C; Patil S; Joshi A; Patil VM; Murthy V; Arya S; Juvekar S; Goud S; Prabhash K
    J Laryngol Otol; 2016 Sep; 130(9):833-42. PubMed ID: 27456399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Kamnerdsupaphon P; Chitapanarux I; Lorvidhaya V; Sumitsawan Y; Tharavichitkul E; Sukthomya V
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1869-73. PubMed ID: 19011334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
    Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV
    Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of advanced head and neck cancer by TPF].
    Watanabe A; Taniguchi M; Tsujizakae H; Toyama T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1240-3. PubMed ID: 20684089
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
    Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can erlotinib ameliorate cisplatin-induced toxicities?
    Sprowl JA; Mathijssen RH; Sparreboom A
    J Clin Oncol; 2013 Sep; 31(27):3442-3. PubMed ID: 23960178
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
    Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
    Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy in advanced head and neck cancer.
    Lorvidhaya V; Punpae P; Tonusin A; Sumitrasawan Y; Changwiwit W
    J Med Assoc Thai; 1986 Apr; 69(4):179-83. PubMed ID: 3723047
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of mammalian target of rapamycin in patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
    Li SH; Lin WC; Huang TL; Chen CH; Chiu TJ; Fang FM; Huang WT; Hsu CM; Luo SD; Lai CC; Su YY; Chuang HC; Chien CY
    Head Neck; 2016 Apr; 38 Suppl 1():E844-52. PubMed ID: 25917382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck: In Regard to Inohara et al.
    Puthiyottil SS; Bhattacharyya T; Purushothaman K; Muttath G
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):469-70. PubMed ID: 26383688
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective study to assess the efficacy and toxicity of 5-flurouracil and cisplatin versus taxane and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer in a regional cancer center in India.
    Lakshmaiah KC; Rudresha AH; Suresh TM; Lokanatha D; Babu GK; Jacob LA
    Indian J Cancer; 2015; 52(1):65-8. PubMed ID: 26837977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does TPF improve survival over PF?
    Pointreau Y; Atean I; Calais G
    Lancet Oncol; 2011 May; 12(5):420-1; author reply 421-2. PubMed ID: 21536219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.